Aliskiren Hemifumarate/Hydrochlorothiazide
半延胡索酸阿利吉仑/氢氯噻嗪
Report date: 2026/01/21 14:10:56
Base Information
Drug NameAliskiren Hemifumarate/Hydrochlorothiazide
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2008/01/18
Country/Territory
CombinationsYes HydrochlorothiazideAliskiren Hemifumarate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNoden Pharma DacNovartis Pharma Ag
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksKEGG